Amway announced it is enhancing its collaboration with HEM Pharma, a microbiome solutions company, as part of its commitment to innovate within the gut health category. The two entities have partnered together for the last decade as they work to advance research, technology and services in the field of microbiome health in the markets where Amway has operations.
Together, the two companies have developed one of the largest gut microbiome databases in the world, which they believe will drive health insights and offer informed strategic growth initiatives.
Amway will now extend its microbiome research into Japan, Thailand, Malaysia, Taiwan and the US, while it also enhances its innovation partnership ecosystem to support nutrition, skin health, oral health and clean air and water solutions.
“As part of Amway’s continued vision to help people live better lives, we’re committed to uncovering new insights that inspire innovative lifestyle, product and service solutions, empowering ABOs and enhancing the Amway customer experience worldwide,” said Amway Chief Research & Development Officer Kristi Pelc.
